Suppr超能文献

门诊患者的抗菌药物管理(OPAT):传染病专家处方评估的影响。

Antimicrobial stewardship in the outpatient parenteral antimicrobial therapy (OPAT) setting: the impact of prescription assessment by an infectious diseases specialist.

机构信息

NotreDame Intermédica Advanced Outpatient Clinic, São Paulo, SP, Brazil.

出版信息

Braz J Infect Dis. 2021 Mar-Apr;25(2):101560. doi: 10.1016/j.bjid.2021.101560. Epub 2021 Mar 11.

Abstract

OBJECTIVE

In recent years, the use of outpatient parenteral antimicrobial therapy (OPAT) has increased, resulting in the need to ensure its rational and adequate utilization. This article describes the implementation of an antimicrobial stewardship program in the OPAT setting by a Health Maintenance Organization (HMO) and its results.

METHOD

An infectious disease (ID) physician made routine assessments of all home care parenteral antimicrobial requests from February to December 2019. Information on diagnosis, renal function, weight, previous antimicrobials, and microbiology were gathered during remote evaluations. Prescription changes recommended by the ID specialist were not mandatory, but implemented by the primary provider as accepted. Antibiotic consumption data was analyzed from January 2018 to December 2019. An active screening was conducted for treatment failures: two or more treatment course requirements, or death within 15 days of the evaluation were reexamined.

RESULTS

A total of 506 antimicrobial requests were assessed. The most frequent diagnoses were urinary tract infection, pneumonia, and orthopedic surgical site infection. Six percent of evaluations were not completed due to insufficient information and 12% were requests by the primary physician for initial antimicrobial guidance. Of the 416 completed prescriptions evaluations, 58% had suggested changes, including different antimicrobials (40%), treatment duration (25%), and route of administration (23%). There was an increase in use of teicoplanin and meropenem, and a decrease in ceftriaxone, ertapenem, cefepime, amikacin and daptomycin use. The HMO's overall parenteral antimicrobial outpatient consumption, which had shown an upward trend over the previous year, decreased after program initiation. No major adverse results were detected in patients' clinical outcomes; two treatment failures were detected and promptly corrected; no deaths attributed to antibiotic changes were detected.

CONCLUSION

Outpatient antimicrobial stewardship, through remote assessment by an ID specialist, was effective and safe in the OPAT setting.

摘要

目的

近年来,门诊患者的肠外抗菌治疗(OPAT)的应用有所增加,因此需要确保其合理和充分利用。本文描述了一家医疗保健组织(HMO)在 OPAT 环境下实施抗菌药物管理计划及其结果。

方法

一名传染病(ID)医生在 2019 年 2 月至 12 月期间对所有家庭护理肠外抗菌药物申请进行常规评估。在远程评估期间收集有关诊断、肾功能、体重、以前使用的抗菌药物和微生物学的信息。ID 专家推荐的处方变更并非强制性的,但由初级保健提供者根据接受程度进行实施。从 2018 年 1 月到 2019 年 12 月分析抗生素消耗数据。对治疗失败进行主动筛查:两次或更多次治疗疗程要求,或在评估后 15 天内死亡的患者,重新检查。

结果

共评估了 506 个抗菌药物申请。最常见的诊断是尿路感染、肺炎和骨科手术部位感染。由于信息不足,有 6%的评估未完成,12%的申请是由初级医师进行初始抗菌药物指导。在完成的 416 个处方评估中,有 58%的建议进行变更,包括使用不同的抗菌药物(40%)、治疗持续时间(25%)和给药途径(23%)。替考拉宁和美罗培南的使用增加,头孢曲松、厄他培南、头孢吡肟、阿米卡星和达托霉素的使用减少。在该计划启动后,HMO 的整体肠外抗菌药物门诊消费呈上升趋势,但在启动后有所下降。在患者的临床结果中没有发现重大不良结果;检测到两个治疗失败并及时纠正;未发现因抗生素变化而导致的死亡。

结论

通过 ID 专家的远程评估,在 OPAT 环境下,门诊抗菌药物管理是有效和安全的。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7fdb/9392152/253db5fc3d99/gr1.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验